SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Curtis Frazier who wrote (21074)4/21/1999 7:28:00 PM
From: VLAD  Read Replies (1) of 23519
 
Curtis,

The conference call was short and to the point and proved 2 important things:

1)Vivus is a very viable company

2)Based on the Alibra, the premature ejaculation product, the female SD cream and gene therapy things do indeed look good on the R&D front.

I think some here who sound disappointed were expecting Leland to announce a domestic partnership with Astra/Zeneca. I believe it will happen sooner than many think.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News